IDH1 and glioma: To explore the relationship between CLIC4 expression and these mutations, we divided lower-grade glioma (LGG) patients into three groups: Group I (IDH mutation with 1p19q codeletion), Group II (IDH mutation without 1p19q codeletion), and Group III (IDH wild-type).